Akros Monthly Payout ETF
MPAY
MPAY was delisted on the 22nd of April, 2025.
1 hedge funds and large institutions have $1.64K invested in Akros Monthly Payout ETF in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.04% less ownership
Funds ownership: 0.13% → 0.08% (-0.04%)
20% less capital invested
Capital invested by funds: $2.04K → $1.64K (-$397)
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$467 |
| 2 |
Morgan Stanley
New York
|
-$32 |
MPAY Hedge Fund Activity: Q1 2024 in Review
1 of the 6,961 institutional investors tracked by Wall St. Rank reported a position in Akros Monthly Payout ETF (MPAY) for Q1 2024, worth a combined $1.64K — down 20% from $2.04K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of MPAY and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was UBS Group, cutting an estimated $467.
- 1 institutional investor held Akros Monthly Payout ETF (MPAY) as of Q1 2024, down from 2 in Q4 2023.
- Funds reported $1.64K of Akros Monthly Payout ETF stock for Q1 2024, down 20% quarter-over-quarter.
- 0 funds opened new Akros Monthly Payout ETF positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Akros Monthly Payout ETF seller in Q1 2024 was UBS Group, an estimated $467 sold.
Based on aggregated 13F filings for Q1 2024.